A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis

NCT03000608 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: SAN021 Serum
DRUG: SAN021 Placebo

Sponsor

Santalis Pharmaceuticals, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]